High incidence of impaired glucose regulation in patients with no known history of diabetes mellitus but with hyperglycemia after undergoing a cardiac surgical procedure

Endocrine Practice

Volumn 15, Issue 5, 2009, Pages 425-430

  Arora, Swati ^a   Gordon, Murray B ^a  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; COHORT ANALYSIS; CORRELATION ANALYSIS; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HEART SURGERY; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROSPECTIVE STUDY; BLOOD; DIABETES MELLITUS; GLUCOSE TOLERANCE TEST; MIDDLE AGED; PATHOPHYSIOLOGY;

AGED; BLOOD GLUCOSE; CARDIAC SURGICAL PROCEDURES; DIABETES MELLITUS; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 70449709712     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP08349.ORR1     Document Type: Article

References (19)

1. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics. Health, United States, 2008 With Chartbook. DHHS Publication 2009-1232. http://www.cdc.gov/nchs/data/hus/hus08.pdf#054. Published March 2009. Accessed for verification April 21, 2009.
2. Centers for Disease Control and Prevention. Estimates of Diagnosed Diabetes Now Available for All U.S. Counties [press release]. June 24, 2008. http://www.cdc.gov/media/pressre/2008/r080624.htm. Accessed for verification April 21, 2009.
3. Garber AJ, Handelsman Y, Einhorn D, et al. Diagnosis and management of prediabetes in the continuum of hyperglycemia - when do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists. Endocr Pract. 2008;14:933-946.
4. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359-1367.
5. Van den Berghe GH. Role of intravenous insulin therapy in critically ill patients. Endocr Pract. 2004;10(suppl 2):17-20.
6. Furnary AP, Wu Y, Bookin SO. Effect of hyperglycemia and continuous intravenous infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract. 2004;10(suppl 2):21-33.
7. Furnary AP, Wu Y. Clinical effects of hyperglycemia in the cardiac surgery population: the Portland Diabetic Project. Endocr Pract. 2006;12(suppl 3):22-26.
8. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2009;32(suppl 1):S62-S67.
9. Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med. 2002;19:708-723.
10. Gerstein HC, Pogue J, Mann JF, et al (HOPE Investigators). The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis. Diabetologia. 2005;48:1749-1755.
11. Knowler WC, Barrett-Connor E, Fowler SE, et al (Diabetes Prevention Program Research Group). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403.
12. Barr EL, Zimmet PZ, Welborn TA, et al. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation. 2007;116:151-157.
13. Lauruschkat AH, Arnrich B, Albert AA, et al. Prevalence and risks of undiagnosed diabetes mellitus in patients undergoing coronary artery bypass grafting. Circulation. 2005;112:2397-2402.
14. Scrutinio D, Giannuzzi P. Comorbidity in patients undergoing coronary artery bypass graft surgery: impact on outcome and implications for cardiac rehabilitation. Eur J Cardiovasc Prev Rehabil. 2008;15:379-385.
15. Farrer M, Fulcher G, Albers CJ, Neil HA, Adams PC, Alberti KG. Patients undergoing coronary artery bypass graft surgery are at high risk of impaired glucose tolerance and diabetes mellitus during the first postoperative year. Metabolism. 1995;44:1016-1027.
16. Norhammar A, Tenerz A, Nilsson G, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet. 2002;359:2140-2144.
17. Robles-Osorio L, Aguilar-Salinas CA, Mehta R, Gómez- Pérez FJ, Rull JA. Analysis of fasting plasma glucose values for optimal detection of abnormal responses on the oral glucose tolerance test in at-risk study subjects. Endocr Pract. 2007;13:583-589.
18. Rydén L, Standl E, Bartnik M, et al (Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology [ESC] and the European Association for the Study of Diabetes [EASD]). Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary; the Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 2007;28:88-136.
19. Wallander M, Malmberg K, Norhammar A, Rydén L, Tenerz A. Oral glucose tolerance test: a reliable tool for early detection of glucose abnormalities in patients with acute myocardial infarction in clinical practice; a report on repeated oral glucose tolerance tests from the GAMI study. Diabetes Care. 2008;31:36-38.